Clinical trial
A Phase 2 Trial Testing ZP1848 in Patients With SBS
NCT02690025 is registered in ClinicalTrials.gov with Zealand Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Trial Testing ZP1848 in Patients With SBS
- Lead sponsor
- Zealand Pharma
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- May 31, 2017
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.